Philips CX50 xMATRIX Offers World-Class Interventional and Diagnostic Features on Single Portable System

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHIA) announced that CX50 xMATRIX, the world's first portable ultrasound with Philips' industry leading Live 3D TEE, now offers 2-D Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available Live 3D TEE and ICE is shown in Paris at the EuroPCR, official meeting for the European Association of Percutaneous Cardiovascular Inventions (EAPCI), May 21-24.

Since its launch in 2012, Philips CX50 xMATRIX has been the only ultrasound system with the flexibility of a portable system together with Live 3D TEE capability. Now, Philips has partnered with St. Jude Medical (NYSE:STJ), a global medical device company based in St. Paul, Minn., to integrate the CX50 xMATRIX with the St. Jude Medical ViewFlex™ Xtra Intracardiac Echocardiography (ICE) Catheter. The ViewFlex Xtra ICE catheter is a new, 2-D catheter featuring four-way steering and the unique benefit of single-handed control.

With the increase in minimally invasive structural heart disease (SHD) repairs and electrophyiosology (EP) procedures comes an increase in the need for ICE for visualization of intracardiac anatomy from the right atrium. ICE is commonly used in procedures such as left atrial ablation and closure of Patent Foramen Ovale (PFO) and Atrial Septal Defects (ASD). With Live 3D TEE and ICE both available on the CX50 xMATRIX, interventional teams can visualize these and other repairs that may benefit from Live 3D TEE such as Transcatheter Aortic Valve Implantation (TAVI), multi-fenestrated and irregular ASD closures, and other complex SHD repairs.

The CX50 xMATRIX is an all-in-one imaging solution for cardiac catheterization labs, EP labs and hybrid operating rooms. With both ICE and Live 3D TEE available on a single system, hospitals will not need to rely on scheduling two separate ultrasound systems for various procedures. The CX50 xMATRIX also offers interventional workflow features such as Philips Allura tableside control, automatic patient data exchange, and support for Philips' EchoNavigator - which intelligently combines fluoroscopy and echocardiography.

"Our cardiology customers have clearly told us that one of the most exciting opportunities for patient care involves minimally invasive repairs, and that performing a wide range of procedures requires exceptional ultrasound imaging - not only Philips Live 3D TEE but also world-class ICE," said Conrad Smits, CEO Ultrasound, for Philips Healthcare. "Working with another industry leader, St. Jude Medical, we have created a partnership that delivers a premium compact integrated solution to exceed the clinical and business needs of our cardiology customers."

About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...